131 related articles for article (PubMed ID: 3367085)
21. Bile acid profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
Kihira K; Shimazu K; Kuwabara M; Yoshii M; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
Steroids; 1986; 48(1-2):109-19. PubMed ID: 3660436
[TBL] [Abstract][Full Text] [Related]
22. ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis.
DeBarber AE; Connor WE; Pappu AS; Merkens LS; Steiner RD
Clin Chim Acta; 2010 Jan; 411(1-2):43-8. PubMed ID: 19808031
[TBL] [Abstract][Full Text] [Related]
23. Dehydroxylation of a 7 beta-hydroxy-C27 plant sterol in rat liver.
Boberg KM; Stabursvik A; Björkhem I; Stokke O
Biochim Biophys Acta; 1989 Aug; 1004(3):321-6. PubMed ID: 2758026
[TBL] [Abstract][Full Text] [Related]
24. [Congenital disorders of the bile acid metabolism (3 beta-hydroxy-delta 5-steroid dehydrogenase/isomerase deficiency, delta 4-3-oxosteroid 5 beta-reductase deficiency, cerebrotendinous xanthomatosis, and peroxisomal disorders].
Kondo KH; Maeda Y; Setoguchi T
Ryoikibetsu Shokogun Shirizu; 1995; (8):362-6. PubMed ID: 8581653
[No Abstract] [Full Text] [Related]
25. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis.
Salen G; Polito A
J Clin Invest; 1972 Jan; 51(1):134-40. PubMed ID: 4550120
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
[TBL] [Abstract][Full Text] [Related]
27. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
[TBL] [Abstract][Full Text] [Related]
28. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
Dayal B; Tint GS; Greeley DN; Williams TH; Salen G
Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948
[TBL] [Abstract][Full Text] [Related]
29. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
[TBL] [Abstract][Full Text] [Related]
30. Psychiatric disorders in patients with cerebrotendinous xanthomatosis.
Berginer VM; Foster NL; Sadowsky M; Townsend JA; Siegel GJ; Salen G
Am J Psychiatry; 1988 Mar; 145(3):354-7. PubMed ID: 3344851
[TBL] [Abstract][Full Text] [Related]
31. Biochemical abnormalities in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Berginer V
Dev Neurosci; 1991; 13(4-5):363-70. PubMed ID: 1817043
[TBL] [Abstract][Full Text] [Related]
32. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.
Setoguchi T; Salen G; Tint GS; Mosbach EH
J Clin Invest; 1974 May; 53(5):1393-401. PubMed ID: 4825231
[TBL] [Abstract][Full Text] [Related]
33. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis.
Nakamura T; Matsuzawa Y; Takemura K; Kubo M; Miki H; Tarui S
Metabolism; 1991 Jul; 40(7):741-6. PubMed ID: 1908036
[TBL] [Abstract][Full Text] [Related]
34. A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens.
McKenna P; Morgan SJ; Bosanquet RC; Laker MF
Br J Ophthalmol; 1990 Oct; 74(10):629-30. PubMed ID: 2285688
[TBL] [Abstract][Full Text] [Related]
35. Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis.
Stahl WL; Sumi SM; Swanson PD
J Neurochem; 1971 Mar; 18(3):403-13. PubMed ID: 5559251
[No Abstract] [Full Text] [Related]
36. On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis.
Panzenboeck U; Andersson U; Hansson M; Sattler W; Meaney S; Björkhem I
J Lipid Res; 2007 May; 48(5):1167-74. PubMed ID: 17325385
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.
Wolthers BG; Volmer M; van der Molen J; Koopman BJ; de Jager AE; Waterreus RJ
Clin Chim Acta; 1983 Jun; 131(1-2):53-65. PubMed ID: 6883710
[TBL] [Abstract][Full Text] [Related]
38. Role of the 26-hydroxylase in the biosynthesis of bile acids in the normal state and in cerebrotendinous xanthomatosis. An in vivo study.
Björkhem I; Fausa O; Hopen G; Oftebro H; Pedersen JI; Skrede S
J Clin Invest; 1983 Jan; 71(1):142-8. PubMed ID: 6848555
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis.
Skrede S; Björkhem I; Kvittingen EA; Buchmann MS; Lie SO; East C; Grundy S
J Clin Invest; 1986 Sep; 78(3):729-35. PubMed ID: 3745434
[TBL] [Abstract][Full Text] [Related]
40. Type IIa hyperlipoproteinemia masquerading as cerebrotendinous xanthomatosis.
Ijichi S; Ijichi N; Niina K; Kuriyama M; Izumo S; Nakamura F; Osame M
J Neurol Sci; 1989 Dec; 94(1-3):101-5. PubMed ID: 2614461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
